IS5076A - Aðferð til kristöllunar tetrahýdrópýrídínafleiðu og kristalafbrigði fengin með henni - Google Patents

Aðferð til kristöllunar tetrahýdrópýrídínafleiðu og kristalafbrigði fengin með henni

Info

Publication number: IS5076A
Authority: IS; Iceland
Prior art keywords: crystallizing; variants obtained; obtained therewith; tetrahydropyridine derivative; crystalline variants
Prior art date: 1996-12-23

Application number

IS5076A

Other languages

English (en)

Other versions

IS2357B (is

Inventor

Caron Antoine

Franc Bruno

Monnier Olivier

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-23

Filing date

1999-06-10

Publication date

1999-06-10

1999-06-10 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

1999-06-10 Publication of IS5076A publication Critical patent/IS5076A/is

2008-04-15 Publication of IS2357B publication Critical patent/IS2357B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Nutrition Science (AREA)
Biochemistry (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Toxicology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IS5076A 1996-12-23 1999-06-10 Aðferð til kristöllunar á tetrahýdróafleiðu og kristallaform sem af henni hljótast IS2357B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9615904A FR2757543B1 (fr)	1996-12-23	1996-12-23	Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
PCT/FR1997/002393 WO1998028271A1 (fr)	1996-12-23	1997-12-23	Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Publications (2)

Publication Number	Publication Date
IS5076A true IS5076A (is)	1999-06-10
IS2357B IS2357B (is)	2008-04-15

Family

ID=9499043

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5076A IS2357B (is)	1996-12-23	1999-06-10	Aðferð til kristöllunar á tetrahýdróafleiðu og kristallaform sem af henni hljótast

Country Status (38)

Country	Link
EP (1)	EP0950050B1 (is)
JP (2)	JP4499188B2 (is)
KR (1)	KR100586670B1 (is)
CN (1)	CN1129580C (is)
AR (1)	AR009672A1 (is)
AT (1)	ATE307802T1 (is)
AU (1)	AU736697B2 (is)
BR (1)	BR9714081A (is)
CA (1)	CA2275596C (is)
CO (1)	CO5070688A1 (is)
CZ (1)	CZ296689B6 (is)
DE (1)	DE69734460T2 (is)
DK (1)	DK0950050T3 (is)
DZ (1)	DZ2383A1 (is)
EE (1)	EE04188B1 (is)
EG (1)	EG21567A (is)
ES (1)	ES2251038T3 (is)
FR (1)	FR2757543B1 (is)
HR (1)	HRP970699B1 (is)
HU (1)	HU227425B1 (is)
IL (1)	IL129938A (is)
IN (1)	IN186976B (is)
IS (1)	IS2357B (is)
MY (1)	MY118015A (is)
NO (1)	NO312364B1 (is)
NZ (1)	NZ336130A (is)
PL (1)	PL190494B1 (is)
RS (1)	RS49882B (is)
RU (1)	RU2192416C2 (is)
SA (1)	SA98180971B1 (is)
SI (1)	SI0950050T1 (is)
SK (1)	SK285088B6 (is)
TR (1)	TR199901363T2 (is)
TW (1)	TW518322B (is)
UA (1)	UA60324C2 (is)
UY (1)	UY24825A1 (is)
WO (1)	WO1998028271A1 (is)
ZA (1)	ZA9711576B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2757543B1 (fr) *	1996-12-23	1999-04-02	Sanofi Sa	Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
FR2782082B3 (fr) *	1998-08-05	2000-09-22	Sanofi Sa	Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
US9233186B2 (en)	2010-03-12	2016-01-12	Nippon Shokubai Co., Ltd.	Process for producing water-absorbing resin
EP2643294B1 (en) *	2011-04-15	2016-08-24	Emcure Pharmaceuticals Limited	An improved rilpivirine process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2531707A1 (fr) *	1982-08-16	1984-02-17	Midy Spa	Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2757543B1 (fr) *	1996-12-23	1999-04-02	Sanofi Sa	Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

1996
- 1996-12-23 FR FR9615904A patent/FR2757543B1/fr not_active Expired - Fee Related
1997
- 1997-12-19 AR ARP970106029A patent/AR009672A1/es not_active Application Discontinuation
- 1997-12-22 DZ DZ970233A patent/DZ2383A1/xx active
- 1997-12-22 HR HR970699A patent/HRP970699B1/xx not_active IP Right Cessation
- 1997-12-22 MY MYPI97006233A patent/MY118015A/en unknown
- 1997-12-23 CA CA002275596A patent/CA2275596C/en not_active Expired - Fee Related
- 1997-12-23 HU HU0001387A patent/HU227425B1/hu not_active IP Right Cessation
- 1997-12-23 SK SK828-99A patent/SK285088B6/sk not_active IP Right Cessation
- 1997-12-23 UA UA99063521A patent/UA60324C2/uk unknown
- 1997-12-23 RS YUP-289/99A patent/RS49882B/sr unknown
- 1997-12-23 ZA ZA9711576A patent/ZA9711576B/xx unknown
- 1997-12-23 CN CN97180863A patent/CN1129580C/zh not_active Expired - Fee Related
- 1997-12-23 RU RU99116597/04A patent/RU2192416C2/ru not_active IP Right Cessation
- 1997-12-23 DE DE69734460T patent/DE69734460T2/de not_active Expired - Lifetime
- 1997-12-23 EP EP97952986A patent/EP0950050B1/fr not_active Expired - Lifetime
- 1997-12-23 AU AU56684/98A patent/AU736697B2/en not_active Ceased
- 1997-12-23 TR TR1999/01363T patent/TR199901363T2/xx unknown
- 1997-12-23 EG EG138397A patent/EG21567A/xx active
- 1997-12-23 PL PL97334256A patent/PL190494B1/pl not_active IP Right Cessation
- 1997-12-23 ES ES97952986T patent/ES2251038T3/es not_active Expired - Lifetime
- 1997-12-23 CZ CZ0229299A patent/CZ296689B6/cs not_active IP Right Cessation
- 1997-12-23 CO CO97074792A patent/CO5070688A1/es unknown
- 1997-12-23 NZ NZ336130A patent/NZ336130A/xx not_active IP Right Cessation
- 1997-12-23 AT AT97952986T patent/ATE307802T1/de active
- 1997-12-23 DK DK97952986T patent/DK0950050T3/da active
- 1997-12-23 WO PCT/FR1997/002393 patent/WO1998028271A1/fr not_active Ceased
- 1997-12-23 EE EEP199900264A patent/EE04188B1/xx not_active IP Right Cessation
- 1997-12-23 KR KR1019997005373A patent/KR100586670B1/ko not_active Expired - Fee Related
- 1997-12-23 IN IN3761DE1997 patent/IN186976B/en unknown
- 1997-12-23 UY UY24825A patent/UY24825A1/es not_active IP Right Cessation
- 1997-12-23 BR BR9714081-3A patent/BR9714081A/pt not_active Application Discontinuation
- 1997-12-23 SI SI9730720T patent/SI0950050T1/sl unknown
- 1997-12-23 IL IL12993897A patent/IL129938A/en not_active IP Right Cessation
- 1997-12-23 JP JP52848198A patent/JP4499188B2/ja not_active Expired - Fee Related
1998
- 1998-01-21 TW TW086119629A patent/TW518322B/zh not_active IP Right Cessation
- 1998-03-11 SA SA98180971A patent/SA98180971B1/ar unknown
1999
- 1999-06-10 IS IS5076A patent/IS2357B/is unknown
- 1999-06-22 NO NO19993076A patent/NO312364B1/no not_active IP Right Cessation
2009
- 2009-05-07 JP JP2009112971A patent/JP2009197022A/ja active Pending

Also Published As

Publication number	Publication date
CO5070688A1 (es)	2001-08-28
WO1998028271A1 (fr)	1998-07-02
TR199901363T2 (xx)	1999-08-23
NO993076L (no)	1999-06-22
HRP970699B1 (en)	2007-03-31
DE69734460D1 (de)	2005-12-01
IS2357B (is)	2008-04-15
IL129938A (en)	2004-06-20
AU5668498A (en)	1998-07-17
YU28999A (sh)	2003-01-31
IN186976B (is)	2001-12-22
TW518322B (en)	2003-01-21
EG21567A (en)	2001-12-31
DZ2383A1 (fr)	2002-12-28
CA2275596C (en)	2005-10-11
HUP0001387A3 (en)	2002-03-28
CN1129580C (zh)	2003-12-03
BR9714081A (pt)	2000-05-09
SA98180971B1 (ar)	2006-09-13
ES2251038T3 (es)	2006-04-16
KR20000069504A (ko)	2000-11-25
IL129938A0 (en)	2000-02-29
CZ229299A3 (cs)	1999-09-15
NZ336130A (en)	2001-01-26
EE04188B1 (et)	2003-12-15
UY24825A1 (es)	1998-04-21
PL334256A1 (en)	2000-02-14
EP0950050A1 (fr)	1999-10-20
NO993076D0 (no)	1999-06-22
RS49882B (sr)	2008-08-07
KR100586670B1 (ko)	2006-06-07
NO312364B1 (no)	2002-04-29
AR009672A1 (es)	2000-04-26
EE9900264A (et)	2000-02-15
CN1241180A (zh)	2000-01-12
UA60324C2 (uk)	2003-10-15
SK285088B6 (sk)	2006-06-01
CA2275596A1 (en)	1998-07-02
JP2001507012A (ja)	2001-05-29
FR2757543A1 (fr)	1998-06-26
HK1024002A1 (en)	2000-09-29
MY118015A (en)	2004-08-30
SI0950050T1 (sl)	2006-04-30
DE69734460T2 (de)	2006-07-06
DK0950050T3 (da)	2006-01-23
JP4499188B2 (ja)	2010-07-07
HU227425B1 (en)	2011-05-30
CZ296689B6 (cs)	2006-05-17
RU2192416C2 (ru)	2002-11-10
JP2009197022A (ja)	2009-09-03
PL190494B1 (pl)	2005-12-30
AU736697B2 (en)	2001-08-02
HRP970699A2 (en)	1998-10-31
HUP0001387A2 (hu)	2000-09-28
EP0950050B1 (fr)	2005-10-26
SK82899A3 (en)	1999-12-10
ATE307802T1 (de)	2005-11-15
FR2757543B1 (fr)	1999-04-02
ZA9711576B (en)	1998-06-25

Publication	Publication Date	Title
DK0890359T3 (da)	2002-07-01	Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
IS4940A (is)	1999-01-04	Erýtrómýsín og aðferð við að framleiða þau
DK0811006T3 (da)	2003-08-04	Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
DK0832565T3 (da)	2000-11-20	Mælkeerstatningsprodukt og fremgangsmåde til fremstilling deraf
DK0946190T3 (da)	2003-12-08	Fremgangsmåder og sammensætninger til stimulering af neuritvækst
NO993676L (no)	1999-09-28	FremgangsmÕte for fremstilling og rensing av et N-alkylert aspartamderivat
DK0850004T3 (da)	2000-03-06	Tandbørste og fremgangsmåde til fremstilling af en sådan
PL322501A1 (en)	1998-02-02	Method of obtaining 2-methyl-thiene-bezodiazepin and crystalline forms thereof
DK139696A (da)	1997-06-08	Benskinne og fremgangsmåde til fremstilling heraf
NO985721D0 (no)	1998-12-07	Polymorfer av donepezilhydroklorid og fremstillingsprosess
DK0812133T3 (da)	2003-03-31	Fremgangsmåde til indpakning af enkelte enheder af tyggegummi og således indpakket tyggegummi
NO974500L (no)	1997-11-28	Blandinger og fremgangsmåter for inhibering av trombogenese
IS4805A (is)	1998-07-22	Aðferð til meðhöndlunar og lyfjasamsetning
IS4649A (is)	1998-01-14	Akkerisfestibúnaður og aðferð
DK0734382T3 (da)	2001-03-19	Krystallinske N-acetyl-neuraminsyrederivater og fremgangsmåder til deres fremstilling
DK1214961T3 (da)	2008-04-07	Krystallisationsapparat og krystallisationsmetode
NO995909L (no)	1999-12-02	Krystallinske makrolider og fremgangsmåte for deres fremstilling
DK0711774T3 (da)	2002-04-22	Nye krystallinske cephem-syreadditionssalte og fremgangsmåder til deres fremstilling
IS4779A (is)	1998-06-19	Aðferð til að framleiða felódipín og aðferð til að framleiða lyfjablöndu
IS5076A (is)	1999-06-10	Aðferð til kristöllunar tetrahýdrópýrídínafleiðu og kristalafbrigði fengin með henni
DK0549134T3 (da)	1996-10-14	Fremgangsmåde til udskæring
DK0512547T3 (da)	1997-08-25	Smertekontrollerende præparat og fremgangsmåde til fremstilling deraf
NO952668D0 (no)	1995-07-05	Fremgansmåte til fremstilling av N-alkyl-laktamer
NO308471B1 (no)	2000-09-18	FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbef
NO961931L (no)	1997-11-11	Isolasjonsblokk og fremgangsmåte til fremstilling og anvendelse derav